Buffalo Scientist Advances Therapeutic to Rebuild Damaged Lung Cells
I-Corps alum and University at Buffalo researcher Anna Blumental-Perry is advancing a novel therapeutic designed to rebuild damaged lung cells, a breakthrough that could significantly improve treatment for chronic respiratory diseases, after being awarded $50,000 in seed funding from the SUNY Technology Accelerator Fund. In June 2025, Blumental-Perry completed the BIO I-Corps conference course hosted…